The Global Biocatalyzed Acrylamide (BioACM) Market will grow from USD 4.05 billion in 2025 to USD 6.51 billion by 2031, registering a CAGR of 8.23% during 2026–2031. Biocatalyzed Acrylamide (BioACM) is a high-purity chemical monomer produced through the enzymatic hydration of acrylonitrile using a biological catalyst instead of the traditional copper-based process.
Market growth is primarily supported by increasing demand for polyacrylamide in wastewater treatment and enhanced oil recovery, where high-molecular-weight polymers are essential for flocculation and viscosity modification. The biocatalytic route also supports green chemistry by reducing energy consumption and hazardous waste generation. According to European Bioplastics, global bioplastics production capacity reached 2.47 million tonnes in 2024, highlighting the broader shift toward sustainable polymer ecosystems.
A key challenge for the Biocatalyzed Acrylamide Market is competition from established chemical acrylamide production facilities. Fully depreciated copper-catalysis plants can maintain low marginal production costs, making it difficult for newer biocatalytic facilities to compete on price without regulatory or sustainability incentives. Volatility in acrylonitrile prices further creates uncertainty around production margins and investment decisions.
The Biocatalyzed Acrylamide Market is valued at USD 4.05 billion in 2025 and is projected to reach USD 6.51 billion by 2031, expanding at a CAGR of 8.23% from 2026 to 2031. The Water Treatment segment is the fastest-growing segment, while North America represents the largest regional market.
| Market Indicator | Details |
|---|---|
| Forecast Period | 2027–2031 |
| Market Size (2025) | USD 4.05 Billion |
| CAGR (2026–2031) | 8.23% |
| Fastest Growing Segment | Water Treatment |
| Largest Market | North America |
| Market Size (2031) | USD 6.51 Billion |
Growing global demand for polyacrylamide in water and wastewater treatment is a major driver of the Biocatalyzed Acrylamide Industry. Municipalities and industrial operators increasingly rely on high-molecular-weight polymers for sludge dewatering, water clarification, filtration, and impurity removal.
The biocatalytic production route generates acrylamide with fewer impurities than conventional copper-based catalysis, supporting the production of ultra-high-molecular-weight flocculants. According to Black & Veatch's 2024 Water Report, 65% of surveyed water utility leaders identified aging infrastructure as their most significant challenge, reinforcing the need for efficient chemical solutions that improve existing treatment infrastructure.
The global shift toward sustainable manufacturing is accelerating the adoption of biocatalytic production processes. Unlike conventional hydration methods that require higher temperatures and generate heavy-metal waste, biocatalysis can operate under ambient pressure and temperature conditions, supporting lower energy consumption and improved process sustainability.
According to the U.S. Department of Agriculture, the U.S. biobased products sector contributed USD 489 billion in value added to the economy in 2024, reflecting strong momentum behind biological production technologies. This trend also supports downstream polyacrylamide producers, with SNF Group reporting 1.45 million tonnes of polyacrylamide active equivalent production capacity in 2024.
Strong competition from established chemical acrylamide manufacturers remains a significant barrier to the Biocatalyzed Acrylamide Market Forecast. Existing copper-catalysis facilities often benefit from established infrastructure and lower marginal production costs, while new biocatalytic plants require substantial capital investment.
This cost difference is particularly important in price-sensitive applications such as wastewater treatment, where procurement decisions are often influenced by production economics and large-volume requirements. As a result, biocatalytic producers may face pressure on margins when competing directly with conventional acrylamide suppliers.